Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| FIREFLY NEUROSCIENCE, INC.AIFF · Entity 7759 | Director | September 25, 2026 | September 29, 2026 |
| Profound Medical Corp.PROF · Entity 6139 | Director · CEO | May 15, 2025 | May 20, 2025 |
| Stereotaxis, Inc.STXS · Entity 6577 | Director | July 01, 2026 | July 01, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
FIREFLY NEUROSCIENCE, INC.
Report date September 25, 2026 · Filed September 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 216,609 |
Reported balance
After 2026-09-25 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-25 · Grant · Acquired 126,050 · Balance 216,609 F1: On September 25, 2026, the Reporting Person was granted 126,050 deferred stock units ("DSUs") under the Issuer's 2024 Long-Term Incentive Plan, which vest quarterly over a twelve (12)-month period. Each DSU represents a contingent right to receive one share of the Issuer's common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: On September 25, 2026, the Reporting Person was granted 126,050 deferred stock units ("DSUs") under the Issuer's 2024 Long-Term Incentive Plan, which vest quarterly over a twelve (12)-month period. Each DSU represents a contingent right to receive one share of the Issuer's common stock.
Profound Medical Corp.
Report date May 15, 2025 · Filed May 20, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 587,089 |
Ending reported balance
After 2025-05-16 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2025-05-15 · Purchase · Acquired 10,003 · Balance 575,062 F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.30 to $4.35, inclusive. The reporting person undertakes to provide to Profound Medical Corp., any security holder of Profound Medical Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4. Row 2 · 2025-05-16 · Purchase · Acquired 12,027 · Balance 587,089 F2: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.70 to $4.78, inclusive. The reporting person undertakes to provide to Profound Medical Corp., any security holder of Profound Medical Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2) to this Form 4. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.30 to $4.35, inclusive. The reporting person undertakes to provide to Profound Medical Corp., any security holder of Profound Medical Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.
F2: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.70 to $4.78, inclusive. The reporting person undertakes to provide to Profound Medical Corp., any security holder of Profound Medical Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2) to this Form 4.
Stereotaxis, Inc.
Report date July 01, 2026 · Filed July 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,035,560 |
Reported balance
After 2026-07-01 transaction · row 1
1 source rowRow 1 · 2026-07-01 · Grant · Acquired 43,103 · Balance 1,035,560 F1: Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest on the earliest to occur of (i) the fifth anniversary of the date of the award, (ii) the date on which the service of the director on the board of directors terminates, or (iii) a Change of Control (as defined in the award documents). |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest on the earliest to occur of (i) the fifth anniversary of the date of the award, (ii) the date on which the service of the director on the board of directors terminates, or (iii) a Change of Control (as defined in the award documents).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 25, 2026 Filed Sep 29, 2026 20:15 UTC | FIREFLY NEUROSCIENCE, INC. AIFF · Entity 7759 | GrantDeferred Stock Units · Derivative | 126,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-104665 · ownership.xml · derivative · entry 1 Menawat Arun Swarup · CIK 0001685893 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 216,609 Underlying: Common Stock · 126,050 shares Expires not disclosed F1 · derivative.exercise_price: On September 25, 2026, the Reporting Person was granted 126,050 deferred stock units ("DSUs") under the Issuer's 2024 Long-Term Incentive Plan, which vest quarterly over a twelve (12)-month period. Each DSU represents a contingent right to receive one share of the Issuer's common stock. F1 · derivative.exercise_date: On September 25, 2026, the Reporting Person was granted 126,050 deferred stock units ("DSUs") under the Issuer's 2024 Long-Term Incentive Plan, which vest quarterly over a twelve (12)-month period. Each DSU represents a contingent right to receive one share of the Issuer's common stock. F1 · derivative.expiration_date: On September 25, 2026, the Reporting Person was granted 126,050 deferred stock units ("DSUs") under the Issuer's 2024 Long-Term Incentive Plan, which vest quarterly over a twelve (12)-month period. Each DSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| July 01, 2026 Filed Jul 1, 2026 20:00 UTC | Stereotaxis, Inc. STXS · Entity 6577 | GrantCommon Stock | 43,103 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-031531 · ownership.xml · nonDerivative · entry 1 Menawat Arun Swarup · CIK 0001685893 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,035,560 F1 · shares: Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest on the earliest to occur of (i) the fifth anniversary of the date of the award, (ii) the date on which the service of the director on the board of directors terminates, or (iii) a Change of Control (as defined in the award documents). Read SEC document |
| January 02, 2026 Filed Jan 2, 2026 21:15 UTC | Stereotaxis, Inc. STXS · Entity 6577 | GrantCommon Stock | 46,948 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-000120 · ownership.xml · nonDerivative · entry 1 Menawat Arun Swarup · CIK 0001685893 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 992,457 F1 · shares: Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest on the earliest to occur of (i) the fifth anniversary of the date of the award, (ii) the date on which the service of the director on the board of directors terminates, or (iii) a Change of Control (as defined in the award documents). Read SEC document |
| October 28, 2025 Filed Oct 30, 2025 19:48 UTC | FIREFLY NEUROSCIENCE, INC. AIFF · Entity 7759 | GrantDeferred Stock Units · Derivative | 73,892 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-104097 · ownership.xml · derivative · entry 1 Menawat Arun Swarup · CIK 0001685893 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,559 Underlying: Common Stock · 73,892 shares Expires not disclosed F1 · derivative.exercise_price: On October 28, 2025, the Reporting Person was granted 73,892 deferred stock units ("DSUs") under the Issuer's 2024 Long-Term Incentive Plan, which vest quarterly over a twelve (12)-month period. Each DSU represents a contingent right to receive one share of the Issuer's common stock. F1 · derivative.exercise_date: On October 28, 2025, the Reporting Person was granted 73,892 deferred stock units ("DSUs") under the Issuer's 2024 Long-Term Incentive Plan, which vest quarterly over a twelve (12)-month period. Each DSU represents a contingent right to receive one share of the Issuer's common stock. F1 · derivative.expiration_date: On October 28, 2025, the Reporting Person was granted 73,892 deferred stock units ("DSUs") under the Issuer's 2024 Long-Term Incentive Plan, which vest quarterly over a twelve (12)-month period. Each DSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 20:05 UTC | Stereotaxis, Inc. STXS · Entity 6577 | GrantCommon Stock | 43,668 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-017797 · ownership.xml · nonDerivative · entry 1 Menawat Arun Swarup · CIK 0001685893 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 945,509 F1 · shares: Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest on the earliest to occur of (i) the fifth anniversary of the date of the award, (ii) the date on which the service of the director on the board of directors terminates, or (iii) a Change of Control (as defined in the award documents). Read SEC document |
| May 19, 2025 Filed May 20, 2025 23:13 UTC | FIREFLY NEUROSCIENCE, INC. AIFF · Entity 7759 | GrantRestricted Stock Units · Derivative | 125,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-017885 · rdgdoc.xml · derivative · entry 1 Menawat Arun Swarup · CIK 0001685893 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires not disclosed F1 · kind: On May 19, 2025, the Reporting Person was granted restricted stock units under the Issuer's 2024 Long-Term Incentive Plan ("Plan") for 125,000 shares of common stock, in consideration of the services to be rendered by the Reporting Person to the Company, which shall vest quarterly over a period of three years from May 19, 2025, subject to satisfaction of the Reporting Person's continuous service. F1 · derivative.exercise_date: On May 19, 2025, the Reporting Person was granted restricted stock units under the Issuer's 2024 Long-Term Incentive Plan ("Plan") for 125,000 shares of common stock, in consideration of the services to be rendered by the Reporting Person to the Company, which shall vest quarterly over a period of three years from May 19, 2025, subject to satisfaction of the Reporting Person's continuous service. F1 · derivative.expiration_date: On May 19, 2025, the Reporting Person was granted restricted stock units under the Issuer's 2024 Long-Term Incentive Plan ("Plan") for 125,000 shares of common stock, in consideration of the services to be rendered by the Reporting Person to the Company, which shall vest quarterly over a period of three years from May 19, 2025, subject to satisfaction of the Reporting Person's continuous service. Read SEC document |
| May 16, 2025 Filed May 20, 2025 17:56 UTC | Profound Medical Corp. PROF · Entity 6139 | PurchaseCommon Shares | 12,027 | $4.73 | $56,887.71 |
DisclosureSEC source: 0001171843-25-003336 · ownership.xml · nonDerivative · entry 2 Menawat Arun Swarup · CIK 0001685893 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 587,089 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.70 to $4.78, inclusive. The reporting person undertakes to provide to Profound Medical Corp., any security holder of Profound Medical Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| May 15, 2025 Filed May 20, 2025 17:56 UTC | Profound Medical Corp. PROF · Entity 6139 | PurchaseCommon Shares | 10,003 | $4.33 | $43,262.98 |
DisclosureSEC source: 0001171843-25-003336 · ownership.xml · nonDerivative · entry 1 Menawat Arun Swarup · CIK 0001685893 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 575,062 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.30 to $4.35, inclusive. The reporting person undertakes to provide to Profound Medical Corp., any security holder of Profound Medical Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 22:05 UTC | FIREFLY NEUROSCIENCE, INC. AIFF · Entity 7759 | GrantDeferred Stock Units · Derivative | 16,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-007342 · rdgdoc.xml · derivative · entry 1 Menawat Arun Swarup · CIK 0001685893 · Director · Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,667 Underlying: Common Stock · 16,667 shares Expires not disclosed F1 · derivative.exercise_price: On March 10, 2025, the Reporting Person was granted 16,667 DSUs under the Issuer's 2024 Long-Term Incentive Plan. A total of 8,333 DSUs vested immediately on the date of grant. Another 4,167 DSUs will vest on June 10, 2025, and an additional 4,167 DSUs will vest on September 10, 2025. Each DSU represents a contingent right to receive one share of common stock of the Issuer. F1 · derivative.exercise_date: On March 10, 2025, the Reporting Person was granted 16,667 DSUs under the Issuer's 2024 Long-Term Incentive Plan. A total of 8,333 DSUs vested immediately on the date of grant. Another 4,167 DSUs will vest on June 10, 2025, and an additional 4,167 DSUs will vest on September 10, 2025. Each DSU represents a contingent right to receive one share of common stock of the Issuer. F1 · derivative.expiration_date: On March 10, 2025, the Reporting Person was granted 16,667 DSUs under the Issuer's 2024 Long-Term Incentive Plan. A total of 8,333 DSUs vested immediately on the date of grant. Another 4,167 DSUs will vest on June 10, 2025, and an additional 4,167 DSUs will vest on September 10, 2025. Each DSU represents a contingent right to receive one share of common stock of the Issuer. Read SEC document |
| January 02, 2025 Filed Jan 2, 2025 22:30 UTC | Stereotaxis, Inc. STXS · Entity 6577 | GrantCommon Stock | 56,497 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-000100 · ownership.xml · nonDerivative · entry 1 Menawat Arun Swarup · CIK 0001685893 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 901,841 F1 · shares: Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest on the earliest to occur of (i) the fifth anniversary of the date of the award, (ii) the date on which the service of the director on the board of directors terminates, or (iii) a Change of Control (as defined in the award documents). Read SEC document |
| July 01, 2024 Filed Jul 1, 2024 21:30 UTC | Stereotaxis, Inc. STXS · Entity 6577 | GrantCommon Stock | 53,475 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-025866 · ownership.xml · nonDerivative · entry 1 Menawat Arun Swarup · CIK 0001685893 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 845,344 F1 · shares: Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest on the earliest to occur of (i) the fifth anniversary of the date of the award, (ii) the date on which the service of the director on the board of directors terminates, or (iii) a Change of Control (as defined in the award documents). Read SEC document |
| January 02, 2024 Filed Jan 2, 2024 22:00 UTC | Stereotaxis, Inc. STXS · Entity 6577 | GrantCommon Stock | 64,935 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-000114 · ownership.xml · nonDerivative · entry 1 Menawat Arun Swarup · CIK 0001685893 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 791,869 F1 · shares: Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest on the earliest to occur of (i) the fifth anniversary of the date of the award, (ii) the date on which the service of the director on the board of directors terminates, or (iii) a Change of Control (as defined in the award documents). Read SEC document |
| July 03, 2023 Filed Jul 3, 2023 20:05 UTC | Stereotaxis, Inc. STXS · Entity 6577 | GrantCommon Stock | 47,619 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-023295 · ownership.xml · nonDerivative · entry 1 Menawat Arun Swarup · CIK 0001685893 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 726,934 F1 · shares: Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest on the earliest to occur of (i) the fifth anniversary of the date of the award, (ii) the date on which the service of the director on the board of directors terminates, or (iii) a Change of Control (as defined in the award documents). Read SEC document |
| January 03, 2023 Filed Jan 3, 2023 21:10 UTC | Stereotaxis, Inc. STXS · Entity 6577 | GrantCommon Stock | 54,054 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-000121 · ownership.xml · nonDerivative · entry 1 Menawat Arun Swarup · CIK 0001685893 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 679,315 F1 · shares: Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest on the earliest to occur of (i) the fifth anniversary of the date of the award, (ii) the date on which the service of the director on the board of directors terminates, or (iii) a Change of Control (as defined in the award documents). Read SEC document |
| July 01, 2022 Filed Jul 1, 2022 20:00 UTC | Stereotaxis, Inc. STXS · Entity 6577 | GrantCommon Stock | 15,527 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-018356 · ownership.xml · nonDerivative · entry 1 Menawat Arun Swarup · CIK 0001685893 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 625,261 F1 · shares: Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest on the earliest to occur of (i) the fifth anniversary of the date of the award, (ii) the date on which the service of the director on the board of directors terminates, or (iii) a Change of Control (as defined in the award documents). Read SEC document |
| January 04, 2022 Filed Jan 4, 2022 21:05 UTC | Stereotaxis, Inc. STXS · Entity 6577 | GrantCommon Stock | 10,449 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-000296 · ownership.xml · nonDerivative · entry 1 Menawat Arun Swarup · CIK 0001685893 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 609,734 F1 · shares: Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest on the earliest to occur of (i) the fifth anniversary of the date of the award, (ii) the date on which the service of the director on the board of directors terminates, or (iii) a Change of Control (as defined in the award documents). Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 15:12 UTC | Stereotaxis, Inc. STXS · Entity 6577 | GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-016172 · ownership.xml · nonDerivative · entry 1 Menawat Arun Swarup · CIK 0001685893 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 599,285 F1 · shares: Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest on the earliest to occur of (i) the fifth anniversary of the date of the award, (ii) the date on which the service of the director on the board of directors terminates, or (iii) a Change of Control (as defined in the award documents). Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 16:32 UTC | Stereotaxis, Inc. STXS · Entity 6577 | GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-000294 · ownership.xml · nonDerivative · entry 1 Menawat Arun Swarup · CIK 0001685893 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 569,285 F1 · shares: Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest on the earliest to occur of (i) the fifth anniversary of the date of the award, (ii) the date on which the service of the director on the board of directors terminates, or (iii) a Change of Control (as defined in the award documents). Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 21:18 UTC | Stereotaxis, Inc. STXS · Entity 6577 | GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-20-012665 · ownership.xml · nonDerivative · entry 1 Menawat Arun Swarup · CIK 0001685893 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 539,285 F1 · shares: Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest on the earliest to occur of (i) the fifth anniversary of the date of the award, (ii) the date on which the service of the director on the board of directors terminates, or (iii) a Change of Control (as defined in the award documents). Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:10 UTC | Stereotaxis, Inc. STXS · Entity 6577 | GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-20-000220 · ownership.xml · nonDerivative · entry 1 Menawat Arun Swarup · CIK 0001685893 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 509,285 F1 · shares: Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest on the earliest to occur of (i) the fifth anniversary of the date of the award, (ii) the date on which the service of the director on the board of directors terminates, or (iii) a Change of Control (as defined in the award documents). Read SEC document |
| July 01, 2019 Filed Jul 1, 2019 10:15 UTC | Stereotaxis, Inc. STXS · Entity 6577 | GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-19-009943 · ownership.xml · nonDerivative · entry 1 Menawat Arun Swarup · CIK 0001685893 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 479,285 F1 · shares: Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest on the earliest to occur of (i) the fifth anniversary of the date of the award, (ii) the date on which the service of the director on the board of directors terminates, or (iii) a Change of Control (as defined in the award documents). Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 18:07 UTC | Stereotaxis, Inc. STXS · Entity 6577 | GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-19-000102 · ownership.xml · nonDerivative · entry 1 Menawat Arun Swarup · CIK 0001685893 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 449,285 F1 · shares: Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest on the earliest to occur of (i) the fifth anniversary of the date of the award, (ii) the date on which the service of the director on the board of directors terminates, or (iii) a Change of Control of the Company (as defined in the award documents). Read SEC document |
| July 02, 2018 Filed Jul 2, 2018 20:16 UTC | Stereotaxis, Inc. STXS · Entity 6577 | GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001289340-18-000067 · edgar.xml · nonDerivative · entry 1 Menawat Arun Swarup · CIK 0001685893 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 419,285 F1 · shares: Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest on the earliest to occur of (i) the fifth anniversary of the date of the award, (ii) the date on which the service of the director on the board of directors terminates, or (iii) a Change of Control of the Company (as defined in the award documents). Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 23:03 UTC | Stereotaxis, Inc. STXS · Entity 6577 | OtherCommon Stock Warrant (right to buy) · Derivative | 153,846 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0001289340-18-000043 · edgar.xml · derivative · entry 4 Menawat Arun Swarup · CIK 0001685893 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 153,846 shares Expires 2021-09-29 Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 23:03 UTC | Stereotaxis, Inc. STXS · Entity 6577 | GrantCommon Stock Warrant (right to buy) · Derivative | 153,846 | Not disclosed Strike: $0.28 | Not disclosed |
DisclosureSEC source: 0001289340-18-000043 · edgar.xml · derivative · entry 3 Menawat Arun Swarup · CIK 0001685893 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,846 Underlying: Common Stock · 153,846 shares Expires 2021-09-29 F1 · date: On February 28, 2018, the issuer and certain holders of outstanding warrants issued pursuant to the Stock Purchase Agreement dated September 26, 2016, including the reporting person, entered into an amendment to the warrants. The amendment provided that the exercise price of the warrants would be reduced for a limited period of time, provided that at least $6 million of warrants was exercised during the limited period. This condition was satisfied on March 1, 2018. F2 · price: The transactions reported in the first two lines of Table II above report the amendment of the warrant to temporarily reduce the exercise price from $0.70 per share to $0.28 per share. The amendment is reported as the disposition of the old warrant and the acquisition of a new one. The amendment to the warrant was approved by a transaction committee consisting solely of independent directors for purposes of Rules 16b-3(d) and (e). Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 23:03 UTC | Stereotaxis, Inc. STXS · Entity 6577 | Disposition to issuerCommon Stock Warrant (right to buy) · Derivative | 153,846 | Not disclosed Strike: $0.70 | Not disclosed |
DisclosureSEC source: 0001289340-18-000043 · edgar.xml · derivative · entry 2 Menawat Arun Swarup · CIK 0001685893 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 153,846 shares Expires 2021-09-29 F1 · date: On February 28, 2018, the issuer and certain holders of outstanding warrants issued pursuant to the Stock Purchase Agreement dated September 26, 2016, including the reporting person, entered into an amendment to the warrants. The amendment provided that the exercise price of the warrants would be reduced for a limited period of time, provided that at least $6 million of warrants was exercised during the limited period. This condition was satisfied on March 1, 2018. F2 · price: The transactions reported in the first two lines of Table II above report the amendment of the warrant to temporarily reduce the exercise price from $0.70 per share to $0.28 per share. The amendment is reported as the disposition of the old warrant and the acquisition of a new one. The amendment to the warrant was approved by a transaction committee consisting solely of independent directors for purposes of Rules 16b-3(d) and (e). Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 23:03 UTC | Stereotaxis, Inc. STXS · Entity 6577 | OtherCommon Stock | 153,846 | $0.28 | $43,076.88 |
DisclosureSEC source: 0001289340-18-000043 · edgar.xml · nonDerivative · entry 1 Menawat Arun Swarup · CIK 0001685893 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 389,285 Read SEC document |
| January 02, 2018 Filed Jan 2, 2018 19:22 UTC | Stereotaxis, Inc. STXS · Entity 6577 | GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001289340-18-000016 · edgar.xml · nonDerivative · entry 1 Menawat Arun Swarup · CIK 0001685893 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,439 F1 · shares: Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest on the earliest to occur of (i) the fifth anniversary of the date of the award, (ii) the date on which the service of the director on the board of directors terminates, or (iii) a Change of Control of the Company (as defined in the award documents). Read SEC document |
| July 03, 2017 Filed Jul 6, 2017 20:07 UTC | Stereotaxis, Inc. STXS · Entity 6577 | GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-17-000534 · edgar.xml · nonDerivative · entry 1 Menawat Arun Swarup · CIK 0001685893 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,439 F1 · shares: Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest on the earliest to occur of (i) the fifth anniversary of the date of the award, (ii) the date on which the service of the director on the board of directors terminates, or (iii) a Change of Control of the Company (as defined in the award documents). Read SEC document |
| December 02, 2016 Filed Dec 6, 2016 21:07 UTC | Stereotaxis, Inc. STXS · Entity 6577 | ConversionSeries A Convertible Preferred Stock · Derivative | 100 | $0.00 Strike: $0.65 | $0.00 |
DisclosureSEC source: 0001289340-16-000157 · edgar.xml · derivative · entry 2 Menawat Arun Swarup · CIK 0001685893 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 155,439 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Initial conversion/exericise price. The conversion/exercise price is subject to adjustment. F2 · derivative.exercise_date: The Series A convertible preferred stock is convertible at the election of the holder at anytime and has no expiration date. F2 · derivative.expiration_date: The Series A convertible preferred stock is convertible at the election of the holder at anytime and has no expiration date. F3 · derivative.underlying_shares: The number of shares of common stock issued upon conversion was calculated based on the stated value of the convertible preferred stock of $1,000 per share increased by the amount of dividends at a rate of 6% per annum, which was cumulative and accrued daily from the date of issuance on the $1,000 stated value and the conversion price of $.65 per share. Read SEC document |
| December 02, 2016 Filed Dec 6, 2016 21:07 UTC | Stereotaxis, Inc. STXS · Entity 6577 | ConversionCommon Stock | 155,439 | $0.65 | $101,035.35 |
DisclosureSEC source: 0001289340-16-000157 · edgar.xml · nonDerivative · entry 1 Menawat Arun Swarup · CIK 0001685893 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,439 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The number of shares of common stock issued upon conversion was calculated based on the stated value of the convertible preferred stock of $1,000 per share increased by the amount of dividends at a rate of 6% per annum, which was cumulative and accrued daily from the date of issuance on the $1,000 stated value and the conversion price of $.65 per share. Read SEC document |
| September 29, 2016 Filed Oct 3, 2016 21:39 UTC | Stereotaxis, Inc. STXS · Entity 6577 | OtherCommon Stock Warrant (right to buy) · Derivative | 153,846 | $0.00 Strike: $0.70 | $0.00 |
DisclosureSEC source: 0001289340-16-000153 · edgar.xml · derivative · entry 3 Menawat Arun Swarup · CIK 0001685893 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,846 Underlying: Common Stock · 153,846 shares Expires 2021-09-29 F2 · derivative.exercise_price: Initial conversion/exercise price. The conversion/exercise price is subject to adjustment. F5 · kind: The warrants were acquired in connection with the purchase of Series A convertible preferred stock. F6 · derivative.underlying_shares: The number of shares is based on the initial exercise price of $.70. The exercise price is subject to adjustment. Read SEC document |
| September 29, 2016 Filed Oct 3, 2016 21:39 UTC | Stereotaxis, Inc. STXS · Entity 6577 | PurchaseSeries A Convertible Preferred Stock · Derivative | 100 | $1,000.00 Strike: $0.65 | $100,000.00 |
DisclosureSEC source: 0001289340-16-000153 · edgar.xml · derivative · entry 2 Menawat Arun Swarup · CIK 0001685893 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100 Underlying: Common Stock · 153,846 shares Expires not disclosed F2 · derivative.exercise_price: Initial conversion/exercise price. The conversion/exercise price is subject to adjustment. F3 · derivative.exercise_date: The Series A convertible preferred stock is convertible at the election of the holder at any time and has no expiration date. F3 · derivative.expiration_date: The Series A convertible preferred stock is convertible at the election of the holder at any time and has no expiration date. F4 · derivative.underlying_shares: The number of shares is based on the initial conversion price of $.65. The conversion price is subject to adjustment. For purposes of determining the number of shares of common stock upon conversion, the value of the convertible preferred stock will be increased by the amount of dividends at a rate of 6% per annum, which will be cumulative and accrue daily from the date of issuance on the $1,000 stated value. Read SEC document |
| September 29, 2016 Filed Oct 3, 2016 21:39 UTC | Stereotaxis, Inc. STXS · Entity 6577 | GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001289340-16-000153 · edgar.xml · nonDerivative · entry 1 Menawat Arun Swarup · CIK 0001685893 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 F1 · shares: Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest over a period of two (2) years with 50% vesting on the first anniversary of the date of the grant and the remaining 50% vesting on the second anniversary of the date of the grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.